Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases

Published:2016-11 Issue:11 Volume:22 Page:2711-2723
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Ghosh Subrata,Sandborn William J.,Colombel Jean-Frederic,Feagan Brian G.,Panaccione Remo,Hanauer Stephen,Schreiber Stefan,Peyrin-Biroulet Laurent,Vermeire Severine,Eichner Samantha,Huang Bidan,Robinson Anne M.,Pappalardo Brandee

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference49 articles.

1. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

2. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

3. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

4. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

5. Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Future of Clinical Trials in Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-07

2. Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review;The Lancet Gastroenterology & Hepatology;2023-12

3. The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitis;The Lancet;2023-04

4. Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies;Journal of Clinical Medicine;2022-11-13

5. Mild to moderate ulcerative colitis: Call me by my name;United European Gastroenterology Journal;2022-08-28